Hetenza Capsules — Enzalutamide 40 mg (112 Capsules) Heet
Hetenza 40 mg (Enzalutamide) is a potent next-generation anti-androgen therapy designed for the treatment of prostate cancer. It acts as a selective androgen receptor signaling inhibitor (ARSI). Unlike first-generation anti-androgens, Hetenza blocks several steps in the androgen receptor signaling pathway that drives the growth of cancer cells.
Manufacturer: Heet Health Care. Hetenza is a high-quality generic version of Enzalutamide, containing the same active pharmaceutical ingredient as the innovator drug, ensuring therapeutic efficacy and adherence to international quality manufacturing standards.
Key Features:
- ✅ Triple Mechanism of Action: Inhibits androgen binding to receptors, prevents nuclear translocation, and blocks DNA binding.
- ✅ Proven Efficacy: Clinically shown to improve overall survival and delay disease progression in patients with advanced prostate cancer.
- ✅ Oral Administration: Convenient capsule form for daily at-home treatment.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.04.2026
What Customers Say
No reviews yet
Your review can be the first!